Board of Directors

Rolf Watter
Chairman of the Board (non-executive)

Chairman of the Nomination and Compensation Committee and Member of the Audit Committee

Member of the Board since 2007

Swiss, born 1958

 

Background:

• Partner at the law firm Bär & Karrer AG in Zurich since 1994
• Executive Member of the Board (2007-2009) and Member of the Executive Board of Bär & Karrer (2000-2009)
• Teaches as a part-time professor at the University of Zurich’s law school

Education:

• Doctorate in Law from the University of Zurich
• Master of Law degree from Georgetown University
• Professor of Law at the University of Zurich

Current other assignments:

• Member of the Board of Directors of Zurich Financial Services and its subsidiary Zurich Insurance Company (since 2002)
• Member of the Board of Directors of Syngenta (agribusiness, since 2000)
• Member of the Board of Directors of UBS Alternative Portfolio (fund of hedge funds and private equity, since 2000)
• Member of the Board of Directors of A.W. Faber-Castell (writing, coloring, and creative design products, since 1997)
• Member of the SIX Admission Board (since 2003)
• Member of the Disclosure Commission of Experts of the SIX Swiss Exchange (since 2002)
• Chairman of two charity institutions

Previous assignments:

• Chairman of Cablecom Holding (telecommunications, 2003-2008)
• Non-executive Director of Forbo Holding (flooring systems, 1999–2005)
• Non-executive Director of Feldschlösschen Getränke (beverages, 2001–2004)
• Non-executive Director of Centerpulse (medical devices, 2002–2003)

Holdings as per 31 January 2012:

• Shares: 67,332*
• Staff options: 0

* thereof 2,000 restricted shares granted by the Company, vesting on 30 June 2015 and 11,832 restricted shares granted by the Company, vesting on 30 June 2016.

Raymund Breu
Vice Chairman of the Board (non-executive)

Member of the Audit Committee and Nomination and Compensation Committee

Member of the Board since 2010

Swiss, born 1945

 

Background:

• CFO of Novartis AG and member of its Executive Committee (pharmaceuticals, 1996-2009)

• Head of Group Finance and a Member of the Sandoz Executive Board (pharmaceuticals, 1993-1996)

• Group Treasurer of Sandoz Ltd., Basel, Switzerland (1990-1993)

• Chief Financial Officer of Sandoz Corporation in the United States (1985-1990)

• Head of Finance for Sandoz affiliates in the United Kingdom (1982-1985)

• Joined Treasury Department of the Sandoz Group in 1975

Education:

• PhD in mathematics from the Swiss Federal Institute of Technology (ETH) in Zurich

Other current assignments:

• Member of the Board of Directors of Swiss Re (reinsurer)

• Member and Vice Chairman of the Swiss Takeover Board (since 2002 and as of 2012, respectively).

Holdings as per 31 January 2012:

• Shares: 76,562*

• Staff options: 0

* thereof 2,000 restricted shares granted by the Company, vesting on 30 June 2015 and 4,562 restricted shares granted by the Company, vesting on 30 June 2016.

Daniela Bosshardt-Hengartner
Non-executive Member

Member of the Nomination and Compensation Committee and of the Innovation and Technology Committee

Member of the Board since 2010

Swiss, born 1972

 

Background:

• Management consultant in the healthcare sector (since 2004)

• Financial analyst at M2 Capital Management AG, a private equity investment firm (2003-2004)

• Covered the fields of medical technology, pharma and biotechnology for Bank am Bellevue (1998-2002)

Education:

• MSc in Pharmaceutical Sciences from the Swiss Federal Institute of Technology (ETH) in Zurich

Current other assignments:

• Board member of Vifor Pharma, Switzerland (since 2006)

• Board member of Galenica, Switzerland (healthcare, since 2008)

• Board member of Prothor Holding SA/Manufacture La-Joux Perret, Switzerland (high-tech mechanical clockwork, since 2009)

• Board member of RepRisk, Switzerland (environmental and social risks - data provider, since 2010)

Holdings as per 31 January 2012:

• Shares: 6,562*

• Staff options: 0

* thereof 2,000 restricted shares granted by the Company, vesting on 30 June 2015 and 4,562 restricted shares granted by the Company, vesting on 30 June 2016.

Edgar Fluri
Non-executive Member

Chairman of the Audit Committee

Member of the Board since 2008

Swiss, born 1947

 

Background:

• Chairman (1998–2008) of PricewaterhouseCoopers, Switzerland (assurance, tax & legal and advisory services); head of Assurance and Business Advisory Services EMEA (1998–2001) and member of the Global Board of PricewaterhouseCoopers (2002–2005)
• Chairman (1996–1998) and Deputy Chairman (1991–1996) of the management committee of STG-Coopers & Lybrand, Switzerland 
• Member of Coopers & Lybrand International and European Boards (1996–1998) 
• Joined STG-Coopers & Lybrand in 1977 and had become a partner in 1986
• Part-time lecturer in public accounting and auditing at the University of Basel  

Education:

• Doctorate in economics and business administration from Basel University
• Swiss Certified Public Accountant (CPA)

Current other assignments:

• Member of the Board of Directors of Orior AG, Zurich (premium convenience food)
• Member of the Supervisory Board of Brenntag AG, Mülheim an der Ruhr, Germany (chemical distribution)
• Member of the Board of Trustees of Beyeler Foundation, Basel, Member of the Board of Beyeler Museum AG and of the Board of Galerie Beyeler AG, Basel
• Member of the Swiss accounting standards body (Swiss GAAP FER)

Previous assignments:

• Member of the Board of the Chamber of Commerce of Basel (1995-2008)
• Member of the Board of the Swiss Institute of Certified Public Accountants (1995 – 2007)

Holdings as per 31 January 2012:

• Shares: 23,062*
• Staff options: 0

* thereof 2,000 restricted shares granted by the Company, vesting on 30 June 2015 and 4,562 restricted shares granted by the Company, vesting on 30 June 2016.

Michel Orsinger
Non-executive Member

Chairman of the Innovation and Technology Committee

Member of the Board since 2012

Swiss, born 1957
 

Background:

• President and CEO of Synthes (medical devices), Inc. since 2007, joined Synthes in 2004 as COO
• Various executive management positions with Novartis, including President and CEO of OTC Worldwide
• Management positions with Procter & Gamble (consumer goods) and Mars (nutrition; 1983-1993)

Education:

• Degree in Business Administration from the University of St. Gallen (Switzerland)
• Advanced Management Program, Harvard Business School (USA)
• Advanced Management Program, INSEAD (France).

Current other assignments:

• President and CEO of Synthes, Inc.

Previous assignments:

• Member of the Nobel Biocare Board of Directors from (2004-2006).

Juha Räisänen
Non-executive Member

Member of the Board since 2012

Finnish, born 1958
 

Background:

• Senior Vice President Supply Chain and Manufacturing of Kone Corporation (elevators and escalators), based in Shanghai, China (since 2008)
• Before joining Kone, he was Senior Vice President of Worldwide Operations and Supply Chain at SanDisk Corp. (electronic devices) 
• Served as Vice President of Nokia Corporation (telecommunication), where he was in charge of the supply chain and operations, as well as systems solutions development for the entire corporation
• Previously, he was in charge of various operations, logistics and sourcing organizations on a regional or business division level in both Asia and Europe
• Prior to Nokia, he worked in various sales, consultant and executive roles, including enterprise systems projects and systems integration at ICL Fujitsu (IT) 
• In addition, he was an Editor and Co-editor for a variety of industry publications. 

Education:

• Master’s degree in Industrial Engineering, Information Technology and Mechanical Engineering from Helsinki University of Technology.

Current other assignments:

• Member of the Board of Finnair Cargo Oy.

Oern Stuge
Non-executive Member

Member of the Innovation and Technology Committee

Member of the Board since 2010

Norwegian, born 1954

 

Background:

• Chief Executive Officer of Impulse Dynamics NV (healthcare technology, 2010-2011)

• Credited for transforming Medtronic’s (medical technology) cardiac surgery and accelerating the growth of its cardiovascular, neurological and spine businesses as a member of the Medtronic Executive and Operating Committee and President of the Cardiac Surgery Division and President for Medtronic Europe and Central Asia (1998-2009)

• Held senior management positions for Abbott Laboratories Inc. (pharmaceutical and nutritional products) and Medinor A/S (medical technology)

Education:

• Graduated "summa cum laude" in medicine from the University of Oslo

• MBA from IMD in Lausanne

Current other assignments:

• Executive Chairman for Impulse Dynamics (healthcare technology) and Bonesupport AB (bone substitutes)

• Chairman of the Board of Aleva Neurosciences SA and Acarix A/S (cardiac screening)

• Member of the Supervisory Board board of Mediq NV (pharmaceuticals and medical supplies retail and distribution), Systagenix Ltd. (wound management) and Advanced Cardiac Therapeutics Inc.  

• Senior advisor to HealthCap, a life sciences investment fund (life sciences investment fund)

• Senior advisor to Uptake Medical Inc. (medical devices)

Previous assignments:

• Member of the Board of Directors of Eucomed (European industry association for medical devices, 2007-2009)

• Member of the Board of Directors of Medicult A/S (In vitro fertilization, 2000-2005)

 

Holdings as per 31 January 2012:

• Shares: 6,562*

• Staff options: 0

* thereof 2,000 restricted shares granted by the Company, vesting on 30 June 2015 and 4,562 restricted shares granted by the Company, vesting on 30 June 2016.

Georg Watzek
Non-executive Member

Member of the Innovation and Technology Committee

Member of the Board since 2012

Austrian, born 1944

 

Background:

• Chairman of the Department of Oral Surgery at the medical school of the University of Vienna (since 1982)

• Chairman of the School of Dentistry (since 1998)

• Renowned expert and lecturer on Oral Surgery, especially on implantology

• President of the European Academy of Osseointegration (EAO; 2003-2004)

• Member of numerous international dental associations, winner of national and international research awards and a recognized lecturer at dental conventions throughout the world 

• Co-publisher of the International Journal of Oral & Maxillofacial Implants, the publication organ of the American Academy of Osseointegration

• Published nine dental textbooks and more than 300 dental clinical and research articles

• Visiting Professor at the University of Pennsylvania (USA) and King Saud University, Riyadh (Kingdom of Saudi Arabia).
  

Education:

• Professor of Oral Surgery, Specialty board examination in Oral and Maxillofacial Surgery

• Doctor of dental surgery (D.D.S.), and a medical doctor (M.D.), from the medical school of the University of Vienna.

Current other assignments:

• No other assignments.